NeoGenomics
(NASDAQ:NEO)
$15.72
0.52[3.42%]
At close: Mar 28
$15.72
0[0.00%]
After Hours: 4:00PM EDT
Consensus Rating1
Buy
Highest Price Target1
$58.00
Lowest Price Target1
$15.00
Consensus Price Target1
$20.46

NeoGenomics Stock (NASDAQ:NEO), Analyst Ratings, Price Targets, Predictions

NeoGenomics Inc has a consensus price target of $20.46, established from looking at the 63 latest analyst ratings. The last 3 analyst ratings were released from Piper Sandler, Goldman Sachs, and Needham on February 26, 2024, February 22, 2024, and February 21, 2024. With an average price target of $21 between Piper Sandler, Goldman Sachs, and Needham, there's an implied 33.59% upside for NeoGenomics Inc from these 3 analyst ratings.

Analyst Rating Summary1

Analyst Ratings
Oct 23
3
1
Nov 23
1
1
Dec 23
3
Feb
3
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Piper Sandler
Goldman Sachs
Needham
TD Cowen
BTIG

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for NeoGenomics

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
02/26/2024NEOBuy Now
NeoGenomics
$15.7227.23%Piper Sandler
David Westenberg
$18 → $20MaintainsOverweightGet Alert
02/22/2024NEOBuy Now
NeoGenomics
$15.7220.87%Goldman Sachs
Matthew Sykes
$17 → $19MaintainsBuyGet Alert
02/21/2024NEOBuy Now
NeoGenomics
$15.7252.67%Needham
Mike Matson
$21 → $24MaintainsBuyGet Alert
12/29/2023NEOBuy Now
NeoGenomics
$15.7220.87%TD Cowen
Dan Brennan
$22 → $19MaintainsOutperformGet Alert
12/29/2023NEOBuy Now
NeoGenomics
$15.7233.59%BTIG
Mark Massaro
$25 → $21MaintainsBuyGet Alert
12/28/2023NEOBuy Now
NeoGenomics
$15.7233.59%Needham
Mike Matson
→ $21ReiteratesBuy → BuyGet Alert
11/08/2023NEOBuy Now
NeoGenomics
$15.728.14%Morgan Stanley
Tejas Savant
$16 → $17MaintainsEqual-WeightGet Alert
11/07/2023NEOBuy Now
NeoGenomics
$15.7233.59%Needham
Mike Matson
→ $21ReiteratesBuy → BuyGet Alert
10/24/2023NEOBuy Now
NeoGenomics
$15.721.78%Morgan Stanley
Tejas Savant
$18 → $16MaintainsEqual-WeightGet Alert
10/23/2023NEOBuy Now
NeoGenomics
$15.728.14%Goldman Sachs
Matthew Sykes
$19 → $17MaintainsBuyGet Alert
10/20/2023NEOBuy Now
NeoGenomics
$15.728.14%Goldman Sachs
Matthew Sykes
$19 → $17MaintainsBuyGet Alert
10/16/2023NEOBuy Now
NeoGenomics
$15.7214.5%Piper Sandler
David Westenberg
$23 → $18MaintainsOverweightGet Alert
08/21/2023NEOBuy Now
NeoGenomics
$15.7214.5%Stephens & Co.
Jacob Johnson
$16 → $18UpgradeEqual-Weight → OverweightGet Alert
08/09/2023NEOBuy Now
NeoGenomics
$15.7214.5%Benchmark
Bruce Jackson
$20 → $18MaintainsBuyGet Alert
08/09/2023NEOBuy Now
NeoGenomics
$15.7214.5%Morgan Stanley
Tejas Savant
$19 → $18MaintainsEqual-WeightGet Alert
08/09/2023NEOBuy Now
NeoGenomics
$15.7233.59%Needham
Mike Matson
→ $21ReiteratesBuy → BuyGet Alert
05/16/2023NEOBuy Now
NeoGenomics
$15.72Raymond James
Andrew Cooper
DowngradeOutperform → Market PerformGet Alert
05/10/2023NEOBuy Now
NeoGenomics
$15.7220.87%Morgan Stanley
Tejas Savant
$18 → $19MaintainsEqual-WeightGet Alert
05/09/2023NEOBuy Now
NeoGenomics
$15.7259.03%BTIG
Mark Massaro
→ $25UpgradeNeutral → BuyGet Alert

FAQ

Q

What is the target price for NeoGenomics (NEO)?

A

The latest price target for NeoGenomics (NASDAQ: NEO) was reported by Piper Sandler on February 26, 2024. The analyst firm set a price target for $20.00 expecting NEO to rise to within 12 months (a possible 27.23% upside). 24 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for NeoGenomics (NEO)?

A

The latest analyst rating for NeoGenomics (NASDAQ: NEO) was provided by Piper Sandler, and NeoGenomics maintained their overweight rating.

Q

When was the last upgrade for NeoGenomics (NEO)?

A

The last upgrade for NeoGenomics Inc happened on August 21, 2023 when Stephens & Co. raised their price target to $18. Stephens & Co. previously had an equal-weight for NeoGenomics Inc.

Q

When was the last downgrade for NeoGenomics (NEO)?

A

The last downgrade for NeoGenomics Inc happened on May 16, 2023 when Raymond James changed their price target from N/A to N/A for NeoGenomics Inc.

Q

When is the next analyst rating going to be posted or updated for NeoGenomics (NEO)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of NeoGenomics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for NeoGenomics was filed on February 26, 2024 so you should expect the next rating to be made available sometime around February 26, 2025.

Q

Is the Analyst Rating NeoGenomics (NEO) correct?

A

While ratings are subjective and will change, the latest NeoGenomics (NEO) rating was a maintained with a price target of $18.00 to $20.00. The current price NeoGenomics (NEO) is trading at is $15.72, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch